Meet Dr. Garnett-Benson -Subject Matter Expert in Cancer immunotherapy and Immunology.

Charlie Garnett-Benson is currently a Scientific Senior Director within Translational Medicine/Precision Medicine, R & D, at Bristol Myers Squibb where she continues to pursue her passion of supporting the development of more effective immuno-oncology drugs for patients with cancer. Previously she was a tenured associate professor in academia, where she ran her own research lab for over a decade, as well as developed and taught courses on Tumor Immunology and Cancer Immunotherapy.  She also served as the Associate Director for Research in her Department before leaving academia to further her career in translational biomedical research.

B.S., Hampton University, Molecular Biology

Ph.D., Emory University, Immunology & Molecular Pathogenesis

Post-doctoral fellowship, National Cancer Institute (NCI), NIH

Training Awards:
Dr. Garnett-Benson is a past recipient of a Minority Access to Research Careers (MARC) scholar award, a National Science Foundation (NSF) minority fellowship, and a Cancer Research Training Award (CRTA) fellowship.

Research Grant Awards:
Dr. Garnett-Benson is a recipient of a research initiation grant from GSU, a mentored grant award from GSU, a subcontract on a NCI R01 research award, a R21 grant from NCI (2012-2015),  a Children’s Leukemia Research Award (2015-2016), and a prestigious Research Scholar Award from the American Cancer Society (2016-2020).

Current Professional Memberships:
American Association for Cancer Research (AACR), member

American Association of Immunologists (AAI), member

Society for the Immunotherapy of Cancer (SITC), current member & past Chair of the Early Career Scientists Committee (2015)

Emory University Winship Cancer Institute, Member